Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases ...

An announcement from Neurocrine ( ($NBIX) ) is now available. On January 24, 2025, Neurocrine Biosciences announced an amendment to its Exclusive ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 52 tables and 51 figures, this 132-page report ?North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease ...

Ballentine Partners LLC grew its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 24.3% in the 4th quarter, according to the company in its most recent filing ...

Keros Therapeutics, Inc. has announced the effectiveness of a global development and commercialization license agreement with ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

BioMed Realty, a Blackstone portfolio company and the largest private operator of life science real estate, alongside Suffolk ...

Investing.com -- Keros Therapeutics, Inc. (NASDAQ: KROS) shares rose 6% following the announcement of the effectiveness of its global license agreement with pharmaceutical giant Takeda. The deal, ...

Endometriosis treatment market Insights. BURLINGAME, CA, UNITED STATES, January 16, 2025 /EINPresswire / -- This report on the Endometriosis Treatment Mark ...

VALLEJO — The Vallejo Symphony will present works by Mahler and Hayden at the Empress Theatre this week, the first Indie ...

When it comes to the bumper $62bn takeover of UK drugs group Shire by its larger Japanese rival Takeda Pharmaceutical (whose shares have returned 32pc since the acquisition completed at the start of ...

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Adults with stage IB-IIIA (American Joint Committee on Cancer seventh edition) resectable NSCLC ...